The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
Sign in to access this content
Sign InReflecting a strategic pivot toward defense and national security sectors, Sòphia High Tech, backed by Genenta Science, reported robust financial results for the fiscal year 2025. According to reports, the company's sales increased by 29.3% to reach €7.17 million, while operating profit surged by 80.8% to €1.21 million. This performance coincides with Genenta Science's evolution into Saentra Forge, an industrial consolidator specifically focused on defense and national security interests.
The significant growth in both revenue and operating profit underscores the success of the company's strategic shift into aerospace, defense, and biotech sectors. These results indicate a substantial improvement in EBITDA margins, strengthening the firm's position within its new industrial consolidation framework. This growth was achieved despite a broader slowdown in regional manufacturing, as market data showed European industrial production fell by 0.2% in mid-July.
Regarding market performance, GNTA shares stood at $1.65 at the close of July 21, 2026, having traded between a low of $1.52 and a high of $1.67 during the session. Investors are now looking for the continued execution of the Saentra Forge strategy in the national security space. While the upcoming economic calendar shows no immediate catalysts for the stock, the focus remains on the long-term integration of its industrial defense assets.